At the news
? NEUTRALIMPACT 2/10 8-K filed Apr 10, 2026 at 16:09 ET
Solid Biosciences Inc. announced a board seat reclassification for director Ilan Ganot, who resigned from Class III and was immediately reappointed to Class I to balance board composition. The move is procedural and does not reflect a change in leadership or strategy.
- Ilan Ganot resigned from Class III of the Board and was reappointed to Class I effective April 10, 2026
- The change was made to achieve equal balance among the three board classes
- No changes to Ganot's compensation or role responsibilities were made
- Stockholders will be asked to ratify the appointment on an advisory basis at the 2026 Annual Meeting
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access